Recognition by METI and TSE
Chugai Pharmaceutical Co., Ltd. has been selected for the "2026 KENKO Investment for Health" by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE). This marks the third consecutive year Chugai has received this recognition for its health management initiatives.
Top 500 Certification
Since 2021, Chugai has been certified as one of the top 500 enterprises in the "Outstanding Organizations of KENKO Investment for Health (Large Enterprise Category)," also known as the "White 500."
Program Overview
The KENKO Investment for Health program, jointly administered by METI and TSE, promotes health management among listed enterprises. It selects companies that integrate employee health management into their strategic initiatives, introducing them to investors focused on long-term corporate value enhancement.
Employee Well-being
Chugai emphasizes employee well-being as a core component of its growth strategy, "TOP I 2030." The company views employee health as foundational to its business activities and continuously implements systems to promote physical and mental health.
